| |
|
|
| Name: |
ORBIMED ADVISORS LLC |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10017 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
100 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
EWTX |
Edgewise Therapeutics, Inc. |
1 |
- |
$22.67 |
$251,710,000 |
15,518,492 |
6.04% |
48,263,000 |
0 |
12.408 |
N/A |
|
|
BSX |
Boston Scientific Corp |
2 |
- |
$96.88 |
$237,173,000 |
2,429,300 |
5.69% |
-64,993,000 |
-383,900 |
0.17 |
Medical Instruments &... |
|
|
LLY |
Eli Lilly & Co |
3 |
- |
$1,059.70 |
$229,816,000 |
301,200 |
5.52% |
-33,353,000 |
-36,400 |
0.031 |
Drug Manufacturers - ... |
|
|
SVA |
Sinovac Biotech Ltd |
4 |
- |
$6.47 |
$184,466,000 |
2,718,735 |
4.43% |
-149,531,000 |
0 |
4.892 |
Drug Manufacturers - ... |
|
|
ELVN |
Enliven Therapeutics Ord Shs |
5 |
- |
$0.00 |
$162,932,000 |
7,959,538 |
3.91% |
3,264,000 |
0 |
12.796 |
N/A |
|
|
ALNY |
Alnylam Pharmaceuticals Inc |
6 |
- |
$436.38 |
$137,530,000 |
301,600 |
3.3% |
26,040,000 |
-40,300 |
0.219 |
Biotechnology |
|
|
SYK |
Stryker Corp |
7 |
- |
$368.27 |
$132,785,000 |
359,200 |
3.19% |
-9,325,000 |
0 |
0.096 |
Medical Instruments &... |
|
|
EW |
Edwards Lifesciences Corp |
8 |
- |
$29.25 |
$130,965,000 |
1,684,000 |
3.14% |
-2,618,000 |
-24,000 |
0.27 |
Medical Appliances & ... |
|
|
ISRG |
Intuitive Surgical Inc |
9 |
- |
$372.63 |
$128,444,000 |
287,200 |
3.08% |
-29,688,000 |
-3,800 |
0.08 |
Medical Appliances & ... |
|
|
ARGX |
Argenx Se |
10 |
- |
$918.92 |
$127,082,000 |
172,300 |
3.05% |
12,428,000 |
-35,700 |
0.367 |
N/A |
|
|
SION |
Sionna Therapeutics, Inc. |
11 |
- |
$0.00 |
$108,963,000 |
3,704,959 |
2.61% |
44,682,000 |
0 |
8.403 |
N/A |
|
|
UPB |
Upstream Bio, Inc. |
12 |
- |
$25.55 |
$107,096,000 |
5,693,589 |
2.57% |
44,580,000 |
0 |
10.743 |
N/A |
|
|
IRON |
Disc Medicine, Inc |
13 |
- |
$92.60 |
$93,505,000 |
1,415,020 |
2.24% |
18,566,000 |
0 |
4.059 |
N/A |
|
|
CAI |
Caris Life Sciences, Inc. |
14 |
- |
$24.09 |
$91,804,000 |
3,034,858 |
2.2% |
10,713,000 |
0 |
1.092 |
N/A |
|
|
SBTX |
Silverback Therapeutics, Inc. |
15 |
- |
$0.00 |
$83,300,000 |
8,288,510 |
2% |
-61,335,000 |
0 |
4.787 |
N/A |
|
|
RNA |
Avidity Biosciences, Inc. |
16 |
- |
$70.56 |
$71,406,000 |
1,638,886 |
1.71% |
19,920,000 |
-174,000 |
1.156 |
N/A |
|
|
MBX |
Mbx Biosciences, Inc. |
17 |
- |
$0.00 |
$70,051,000 |
4,002,887 |
1.68% |
24,378,000 |
0 |
10.689 |
N/A |
|
|
CGON |
CG Oncology, Inc |
18 |
- |
$42.44 |
$69,558,000 |
1,726,850 |
1.67% |
20,734,000 |
-151,000 |
2.257 |
N/A |
|
|
NTRA |
Natera, Inc. |
19 |
- |
$230.63 |
$69,104,000 |
429,300 |
1.66% |
-31,151,000 |
-164,134 |
0.314 |
N/A |
|
|
AXSM |
Axsome Therapeutics, Inc. |
20 |
- |
$149.44 |
$64,587,000 |
531,800 |
1.55% |
19,919,000 |
103,900 |
1.124 |
N/A |
|
|
TERN |
Terns Pharmaceuticals, Inc. |
21 |
- |
$26.32 |
$56,798,000 |
7,562,971 |
1.36% |
28,588,000 |
0 |
9.004 |
N/A |
|
|
AVBP |
Arrivent Biopharma, Inc. |
22 |
- |
$20.35 |
$55,854,000 |
3,027,328 |
1.34% |
-10,051,000 |
0 |
7.462 |
N/A |
|
|
MLYS |
Mineralys Therapeutics, Inc. |
23 |
- |
$0.00 |
$55,723,000 |
1,469,494 |
1.34% |
45,435,000 |
709,143 |
1.097 |
N/A |
|
|
EXAS |
Exact Sciences Corp |
24 |
- |
$100.90 |
$54,415,000 |
994,616 |
1.31% |
22,142,000 |
387,300 |
0.538 |
Biotechnology |
|
|
CMPX |
Compass Therapeutics Ord Shs |
25 |
- |
$0.00 |
$53,270,000 |
15,219,994 |
1.28% |
13,698,000 |
0 |
11.007 |
N/A |
|
|
CRVS |
Corvus Pharmaceuticals, Inc. |
26 |
- |
$8.57 |
$52,806,000 |
7,165,006 |
1.27% |
24,146,000 |
0 |
11.195 |
N/A |
|
|
APLS |
Apellis Pharmaceuticals Inc |
27 |
- |
$19.61 |
$52,578,000 |
2,323,368 |
1.26% |
26,919,000 |
841,068 |
1.75 |
N/A |
|
|
DHR |
Danaher Corp |
28 |
New |
$227.39 |
$52,162,000 |
263,100 |
1.25% |
52,162,000 |
263,100 |
0.037 |
General Building Mate... |
|
|
NBIX |
Neurocrine Biosciences Inc |
29 |
- |
$141.83 |
$49,644,000 |
353,640 |
1.19% |
-5,476,000 |
-84,900 |
0.357 |
Biotechnology |
|
|
UTHR |
United Therapeutics Corp |
30 |
New |
$474.82 |
$48,167,000 |
114,900 |
1.16% |
48,167,000 |
114,900 |
0.243 |
Drug Manufacturers - ... |
|
|
CI |
Cigna Corporation |
31 |
New |
$278.09 |
$46,927,000 |
162,800 |
1.13% |
46,927,000 |
162,800 |
0.044 |
Health Care Plans |
|
|
CRNX |
Crinetics Pharmaceuticals, ... |
32 |
- |
$42.86 |
$45,773,000 |
1,099,000 |
1.1% |
12,728,000 |
-50,000 |
1.027 |
N/A |
|
|
ORIC |
Oric Pharmaceuticals, Inc. |
33 |
- |
$0.00 |
$43,701,000 |
3,641,756 |
1.05% |
34,573,000 |
2,742,475 |
3.75 |
N/A |
|
|
JANX |
Janux Therapeutics, Inc. |
34 |
- |
$0.00 |
$43,163,000 |
1,766,100 |
1.04% |
15,205,000 |
555,800 |
2.53 |
N/A |
|
|
ROIV |
Roivant Sciences Ltd. |
35 |
- |
$20.22 |
$41,075,000 |
2,714,798 |
0.99% |
9,751,000 |
-64,629 |
0.392 |
N/A |
|
|
ASND |
Ascendis Pharma AS |
36 |
- |
$210.49 |
$38,153,000 |
191,905 |
0.92% |
32,216,000 |
157,505 |
0.283 |
N/A |
|
|
SIBN |
Si-Bone, Inc. |
37 |
- |
$0.00 |
$37,963,000 |
2,578,979 |
0.91% |
-10,573,000 |
0 |
6.186 |
N/A |
|
|
SCPH |
Scpharmaceuticals Inc. |
38 |
- |
$0.00 |
$34,358,000 |
6,059,528 |
0.82% |
11,271,000 |
0 |
12.119 |
N/A |
|
|
ABVX |
Abivax S.A |
39 |
New |
$119.12 |
$32,262,000 |
380,000 |
0.77% |
32,262,000 |
380,000 |
0.613 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
40 |
- |
$34.32 |
$31,900,000 |
1,139,300 |
0.77% |
7,027,000 |
-60,000 |
1.808 |
N/A |
|
|
TRVI |
Trevi Therapeutics, Inc. |
41 |
- |
$0.00 |
$30,272,000 |
3,308,400 |
0.73% |
12,175,000 |
0 |
2.717 |
N/A |
|
|
ITGR |
Integer Holdings Corporation |
42 |
- |
$70.00 |
$29,966,000 |
290,000 |
0.72% |
-23,329,000 |
-143,400 |
0.632 |
Industrial Electrical... |
|
|
DYN |
Dyne Therapeutics, Inc. |
43 |
- |
$21.18 |
$29,274,000 |
2,314,184 |
0.7% |
19,455,000 |
1,282,784 |
1.627 |
N/A |
|
|
RAPT |
Rapt Therapeutics, Inc. |
44 |
- |
$1.03 |
$28,024,000 |
1,086,618 |
0.67% |
14,889,000 |
-555,288 |
0.821 |
N/A |
|
|
CTMX |
Cytomx Therapeutics, Inc. |
45 |
- |
$0.00 |
$26,992,000 |
8,461,500 |
0.65% |
7,784,000 |
0 |
5.131 |
N/A |
|
|
NPCE |
Neuropace Inc |
46 |
- |
$14.35 |
$26,952,000 |
2,614,184 |
0.65% |
-2,170,000 |
0 |
10.762 |
N/A |
|
|
QURE |
uniQure B.V. |
47 |
New |
$27.81 |
$26,763,000 |
458,500 |
0.64% |
26,763,000 |
458,500 |
0.837 |
N/A |
|
|
EYPT |
EyePoint Pharmaceuticals Inc |
48 |
New |
$0.44 |
$25,575,000 |
1,796,000 |
0.61% |
25,575,000 |
1,796,000 |
1.251 |
Biotechnology |
|
|
AKRO |
Akero Therapeutics, Inc. |
49 |
- |
$0.00 |
$24,984,000 |
526,200 |
0.6% |
13,709,000 |
314,900 |
0.552 |
N/A |
|
|
ADCT |
ADC Therapeutics Sa |
50 |
- |
$4.02 |
$23,629,000 |
5,907,351 |
0.57% |
7,797,000 |
0 |
8.352 |
N/A |
|
|
TMO |
Thermo Fisher Scientific |
51 |
- |
$587.48 |
$22,553,000 |
46,500 |
0.54% |
3,699,000 |
0 |
0.012 |
Medical Laboratories ... |
|
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
52 |
- |
$101.74 |
$21,728,000 |
215,152 |
0.52% |
6,025,000 |
-33,360 |
0.303 |
N/A |
|
|
KRYS |
Krystal Biotech Inc |
53 |
- |
$212.02 |
$18,138,000 |
102,745 |
0.44% |
16,873,000 |
93,545 |
0.358 |
N/A |
|
|
FBRX |
Forte Biosciences Inc |
54 |
- |
$1.26 |
$17,954,000 |
1,196,955 |
0.43% |
2,477,000 |
0 |
3.294 |
N/A |
|
|
AVTX |
Avalo Therapeutics, Inc |
55 |
- |
$0.43 |
$17,150,000 |
1,349,300 |
0.41% |
12,325,000 |
382,300 |
1.201 |
N/A |
|
|
XENE |
Xenon Pharmaceuticals Inc. |
56 |
- |
$0.00 |
$16,847,000 |
419,600 |
0.4% |
-12,822,000 |
-528,277 |
0.488 |
N/A |
|
|
CARL |
Carlsmed, Inc. |
57 |
New |
$12.49 |
$16,772,000 |
1,252,600 |
0.4% |
16,772,000 |
1,252,600 |
4.713 |
N/A |
|
|
KROS |
Keros Therapeutics, Inc. |
58 |
- |
$0.00 |
$16,116,000 |
1,018,734 |
0.39% |
2,516,000 |
0 |
2.485 |
N/A |
|
|
PRLD |
Prelude Therapeutics Inc |
59 |
- |
$0.00 |
$15,709,000 |
10,909,256 |
0.38% |
6,879,000 |
0 |
24.964 |
N/A |
|
|
STTK |
Shattuck Labs, Inc. |
60 |
New |
$0.00 |
$15,072,000 |
6,306,127 |
0.36% |
15,072,000 |
6,306,127 |
15.108 |
N/A |
|
|
CRBP |
Corbus Pharmaceuticals Hold... |
61 |
- |
$12.01 |
$14,829,000 |
1,172,287 |
0.36% |
6,740,000 |
0 |
0.936 |
N/A |
|
|
URGN |
Urogen Pharma Ltd. |
62 |
- |
$25.87 |
$13,746,000 |
689,000 |
0.33% |
7,192,000 |
210,600 |
1.636 |
N/A |
|
|
VIR |
Vir Biotechnology, Inc. |
63 |
- |
$0.00 |
$13,594,000 |
2,380,715 |
0.33% |
1,595,000 |
0 |
1.869 |
N/A |
|
|
FOLD |
Amicus Therapeutics Inc |
64 |
- |
$10.61 |
$12,966,000 |
1,645,400 |
0.31% |
-129,000 |
-640,000 |
0.484 |
Biotechnology |
|
|
TARS |
Tarsus Pharmaceuticals, Inc. |
65 |
- |
$0.00 |
$11,761,000 |
197,900 |
0.28% |
3,744,000 |
0 |
0.426 |
N/A |
|
|
CCCC |
C4 Therapeutics, Inc. |
66 |
- |
$0.00 |
$11,622,000 |
5,235,146 |
0.28% |
1,855,000 |
-1,595,154 |
7.55 |
N/A |
|
|
CGEM |
Cullinan Oncology Ord Shs |
67 |
- |
$0.00 |
$11,408,000 |
1,923,855 |
0.27% |
-3,079,000 |
0 |
0.442 |
N/A |
|
|
VTGN |
Vistagen Therapeutics Inc |
68 |
New |
$4.59 |
$10,863,000 |
3,060,000 |
0.26% |
10,863,000 |
3,060,000 |
11.321 |
Biotechnology |
|
|
AMLX |
Amylyx Pharmaceuticals, Inc. |
69 |
- |
$0.00 |
$10,201,000 |
750,600 |
0.24% |
8,193,000 |
437,400 |
0.842 |
N/A |
|
|
ACET |
Adicet Bio, Inc |
70 |
- |
$0.60 |
$9,274,000 |
11,447,140 |
0.22% |
2,291,000 |
0 |
13.892 |
N/A |
|
|
PMVP |
Pmv Pharmaceuticals, Inc. |
71 |
- |
$0.00 |
$8,365,000 |
5,975,291 |
0.2% |
1,501,000 |
-500,000 |
10.985 |
N/A |
|
|
AADI |
Aadi Bioscience, Inc |
72 |
- |
$2.11 |
$7,915,000 |
4,166,000 |
0.19% |
125,000 |
0 |
8.906 |
N/A |
|
|
VSTM |
Verastem, Inc. |
73 |
- |
$10.00 |
$7,837,000 |
887,561 |
0.19% |
7,837,000 |
887,561 |
1.442 |
Biotechnology |
|
|
BTSG |
Brightspring Health Service... |
74 |
New |
$34.59 |
$7,798,000 |
263,800 |
0.19% |
7,798,000 |
263,800 |
0.13 |
N/A |
|
|
ALMS |
Alumis Inc. |
75 |
- |
$7.30 |
$7,686,000 |
1,926,423 |
0.18% |
1,907,000 |
0 |
1.851 |
N/A |
|
|
BCRX |
Biocryst Pharmaceuticals Inc |
76 |
New |
$6.97 |
$6,842,000 |
901,500 |
0.16% |
6,842,000 |
901,500 |
0.429 |
Biotechnology |
|
|
MIST |
Milestone Pharmaceuticals Inc. |
77 |
New |
$0.00 |
$6,444,000 |
3,221,828 |
0.15% |
6,444,000 |
3,221,828 |
4.868 |
N/A |
|
|
RPTX |
Repare Therapeutics Inc. |
78 |
- |
$0.00 |
$5,848,000 |
3,322,488 |
0.14% |
1,230,000 |
0 |
9.041 |
N/A |
|
|
NSPR |
Inspiremd, Inc |
79 |
- |
$0.00 |
$5,142,000 |
2,133,405 |
0.12% |
299,000 |
0 |
9.9 |
N/A |
|
|
BIOA |
Bioage Labs, Inc. |
80 |
- |
$8.65 |
$4,650,000 |
790,901 |
0.11% |
842,000 |
-131,058 |
2.208 |
N/A |
|
|
JBIO |
Jade Biosciences |
81 |
- |
$0.00 |
$4,584,000 |
531,163 |
0.11% |
-722,000 |
0 |
1.596 |
N/A |
|
|
QTTB |
Q32 Bio Inc |
82 |
- |
$2.00 |
$4,461,000 |
2,252,987 |
0.11% |
1,104,000 |
0 |
4.7 |
N/A |
|
|
MNMD |
Mind Medicine |
83 |
New |
$10.68 |
$4,337,000 |
367,824 |
0.1% |
4,337,000 |
367,824 |
0.452 |
N/A |
|
|
CELC |
Celcuity Inc. |
84 |
New |
$97.50 |
$4,151,000 |
84,020 |
0.1% |
4,151,000 |
84,020 |
0.227 |
N/A |
|
|
IMTX |
Immatics N.V |
85 |
- |
$10.20 |
$3,975,000 |
466,601 |
0.1% |
102,000 |
-253,300 |
0.453 |
N/A |
|
|
IMA |
Imagenebio Inc |
86 |
- |
$0.00 |
$3,085,000 |
378,556 |
0.07% |
-1,658,000 |
-3,160,802 |
0.784 |
N/A |
|
|
INSM |
Insmed Inc |
87 |
- |
$198.76 |
$1,938,000 |
13,459 |
0.05% |
583,000 |
0 |
0.006 |
Biotechnology |
|
|
ATAI |
Atai Life Sciences B.v. |
88 |
New |
$3.80 |
$1,836,000 |
347,000 |
0.04% |
1,836,000 |
347,000 |
0.227 |
N/A |
|
|
KRRO |
Korro Bio |
89 |
- |
$0.00 |
$1,552,000 |
32,400 |
0.04% |
1,147,000 |
0 |
0.096 |
N/A |
|
|
MURA |
Mural Oncology Plc |
90 |
- |
$2.09 |
$1,219,000 |
588,800 |
0.03% |
-235,000 |
0 |
3.528 |
N/A |
|
|
TRAW |
Traws Pharma, Inc |
91 |
- |
$2.31 |
$1,120,000 |
605,531 |
0.03% |
224,000 |
0 |
12.111 |
N/A |
|
|
ANRO |
Alto Neuroscience, Inc. |
92 |
- |
$13.25 |
$1,005,000 |
250,000 |
0.02% |
455,000 |
0 |
0.93 |
N/A |
|
|
LYEL |
Lyell Immunopharma, Inc. |
93 |
- |
$19.13 |
$840,000 |
51,727 |
0.02% |
383,000 |
0 |
0.278 |
N/A |
|
|
KZR |
Kezar Life Sciences, Inc. |
94 |
- |
$6.25 |
$752,000 |
192,700 |
0.02% |
-131,000 |
0 |
0.282 |
N/A |
|
|
XERS |
Xeris Pharmaceuticals Inc |
95 |
- |
$6.83 |
$655,000 |
80,420 |
0.02% |
279,000 |
0 |
0.059 |
N/A |
|
|
PASG |
Passage Bio, Inc. |
96 |
- |
$0.40 |
$474,000 |
59,046 |
0.01% |
-1,950,000 |
-5,996,254 |
0.13 |
N/A |
|
|
DHAI |
Dih Holdings US Class A |
97 |
- |
$0.00 |
$358,000 |
1,915,000 |
0.01% |
-111,000 |
0 |
4.724 |
N/A |
|
|
ENGN |
Engene Holdings Inc. |
104 |
Closed |
$6.96 |
$0 |
0 |
0% |
-2,468,000 |
-677,977 |
0 |
N/A |
|
|
LSB |
Lakeshore Biopharma Co Ltd |
111 |
Closed |
$0.00 |
$0 |
0 |
0% |
-56,000 |
-54,799 |
0 |
N/A |
|
|
THRD |
Third Harmonic Bio, Inc. |
103 |
Closed |
$5.38 |
$0 |
0 |
0% |
-31,380,000 |
-5,779,071 |
0 |
N/A |
|
